Andrew W. Thomas

5.7k total citations · 3 hit papers
44 papers, 4.9k citations indexed

About

Andrew W. Thomas is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andrew W. Thomas has authored 44 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Organic Chemistry and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andrew W. Thomas's work include Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (9 papers) and Chemical Synthesis and Analysis (6 papers). Andrew W. Thomas is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (9 papers) and Chemical Synthesis and Analysis (6 papers). Andrew W. Thomas collaborates with scholars based in Switzerland, United Kingdom and United States. Andrew W. Thomas's co-authors include Steven V. Ley, David M. Wilson, Anthony Wood, David C. Rees, Ian Churcher, David C. Blakemore, Luis C. Misal Castro, Frédéric Knoflach, Harry Finch and Maria‐Clemencia Hernandez and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Neuroscience and Chemical Communications.

In The Last Decade

Andrew W. Thomas

44 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation

2004 2.0k citations Andrew W. Thomas et al. profile →
Organic synthesis provides opportunities to transform drug discovery

2018 1.2k citations David C. Blakemore, Luis C. Misal Castro et al. Nature Chemistry profile →
Moderne Synthesemethoden: Kupfer‐vermittelte C(Aryl)‐O‐, C(Aryl)‐N‐ und C(Aryl)‐S‐Verknüpfungen

2003 526 citations Andrew W. Thomas et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Andrew W. Thomas	3.9k	970	498	404	256	44	4.9k
Gérald Guillaumet	4.6k 1.2×	1.8k 1.9×	249 0.5×	343 0.8×	331 1.3×	382	6.0k
Youssef L. Bennani	2.4k 0.6×	2.0k 2.1×	562 1.1×	153 0.4×	131 0.5×	95	4.4k
José L. Castro	1.8k 0.4×	1.7k 1.8×	149 0.3×	697 1.7×	306 1.2×	118	4.4k
Hiroki Takahata	2.8k 0.7×	1.3k 1.3×	225 0.5×	268 0.7×	84 0.3×	199	3.8k
Shahid Hameed	1.8k 0.5×	1.3k 1.4×	335 0.7×	558 1.4×	266 1.0×	164	3.6k
Leggy A. Arnold	1.9k 0.5×	1.3k 1.4×	890 1.8×	355 0.9×	77 0.3×	114	3.6k
Joseph M. Ready	2.7k 0.7×	902 0.9×	674 1.4×	226 0.6×	135 0.5×	101	4.1k
Takayuki Doi	3.4k 0.9×	1.9k 2.0×	311 0.6×	277 0.7×	230 0.9×	262	5.3k
Scott R. Gilbertson	2.3k 0.6×	1.0k 1.0×	922 1.9×	199 0.5×	84 0.3×	91	2.9k
Satoshi Yokoshima	2.9k 0.7×	1.2k 1.3×	215 0.4×	185 0.5×	99 0.4×	140	4.1k

Countries citing papers authored by Andrew W. Thomas

Since Specialization

Citations

This map shows the geographic impact of Andrew W. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew W. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew W. Thomas more than expected).

Fields of papers citing papers by Andrew W. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew W. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew W. Thomas. The network helps show where Andrew W. Thomas may publish in the future.

Co-authorship network of co-authors of Andrew W. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew W. Thomas. A scholar is included among the top collaborators of Andrew W. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew W. Thomas. Andrew W. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hipp, Joerg F., Frédéric Knoflach, Robert A. Comley, et al.. (2021). Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man. Scientific Reports. 11(1). 7700–7700. 24 indexed citations

Blakemore, David C., Luis C. Misal Castro, Ian Churcher, et al.. (2018). Organic synthesis provides opportunities to transform drug discovery. Nature Chemistry. 10(4). 383–394. 1152 indexed citations breakdown →

Frau, Roberto, Valentina Bini, Giuliano Pillolla, et al.. (2014). Positive Allosteric Modulation ofGABA_BReceptors Ameliorates Sensorimotor Gating in Rodent Models. CNS Neuroscience & Therapeutics. 20(7). 679–684. 11 indexed citations

Maccioni, Paola, Andrew W. Thomas, Pari Malherbe, et al.. (2014). Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen. Psychopharmacology. 232(10). 1831–1841. 30 indexed citations

Martínez‐Cué, Carmen, Paula Martínez, Noemı́ Rueda, et al.. (2013). Reducing GABA _A α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome. Journal of Neuroscience. 33(9). 3953–3966. 122 indexed citations

Loi, Barbara, Paola Maccioni, Carla Lobina, et al.. (2012). Reduction of alcohol intake by the positive allosteric modulator of the GABAB receptor, rac-BHFF, in alcohol-preferring rats. Alcohol. 47(1). 69–73. 32 indexed citations

Maccioni, Paola, Andrew W. Thomas, Mauro A.M. Carai, et al.. (2010). The positive allosteric modulator of the GABAB receptor, rac-BHFF, suppresses alcohol self-administration. Drug and Alcohol Dependence. 109(1-3). 96–103. 43 indexed citations

Ballard, Theresa M., Francesca Blasco, Pierre‐Emmanuel Broutin, et al.. (2009). Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABAA α5 inverse agonist series. Bioorganic & Medicinal Chemistry Letters. 19(19). 5746–5752. 23 indexed citations

Knust, Henner, Theresa M. Ballard, Bernd Buettelmann, et al.. (2009). The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA α5 inverse agonists for the treatment of cognitive dysfunction. Bioorganic & Medicinal Chemistry Letters. 19(20). 5940–5944. 55 indexed citations

10.

Ballard, Theresa M., Frédéric Knoflach, Eric Prinssen, et al.. (2008). RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors. Psychopharmacology. 202(1-3). 207–223. 129 indexed citations

11.

Pinard, Emmanuel, Daniela Alberati, Edilio Borroni, et al.. (2008). Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5134–5139. 18 indexed citations

12.

Malherbe, Pari, Raffaello Masciadri, Roger D. Norcross, et al.. (2008). Characterization of (R,S)‐5,7‐di‐tert‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3H‐benzofuran‐2‐one as a positive allosteric modulator of GABA_Breceptors. British Journal of Pharmacology. 154(4). 797–811. 85 indexed citations

13.

Alberati, Daniela, Simona Ceccarelli, Synèse Jolidon, et al.. (2006). Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: Achieving selectivity against the μ opioid and nociceptin/orphanin FQ peptide (NOP) receptors. Bioorganic & Medicinal Chemistry Letters. 16(16). 4305–4310. 11 indexed citations

14.

Alberati, Daniela, Dominik Hainzl, Synèse Jolidon, et al.. (2006). 4-Substituted-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with superior pharmacological and pharmacokinetic parameters. Bioorganic & Medicinal Chemistry Letters. 16(16). 4321–4325. 7 indexed citations

15.

Alberati, Daniela, Dominik Hainzl, Synèse Jolidon, et al.. (2006). Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability. Bioorganic & Medicinal Chemistry Letters. 16(16). 4311–4315. 15 indexed citations

16.

Alanine, Alexander, Matthias Nettekoven, Edward Roberts, & Andrew W. Thomas. (2003). Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process. Combinatorial Chemistry & High Throughput Screening. 6(1). 51–66. 38 indexed citations

17.

Nettekoven, Matthias & Andrew W. Thomas. (2002). Accelerating Drug Discovery by Integrative Implementation of Laboratory Automation in the Work Flow. Current Medicinal Chemistry. 9(23). 2179–2190. 16 indexed citations

18.

Thomas, Andrew W.. (2002). A concise route to triazolobenzodiazepine derivatives via a one-Pot alkyne-Azide cycloaddition reaction. Bioorganic & Medicinal Chemistry Letters. 12(14). 1881–1884. 40 indexed citations

19.

Thomas, Andrew W., et al.. (1995). Sigmoidorectal Intussusception from a Sigmoid Lipoma. Journal of Clinical Gastroenterology. 21(3). 257–257. 10 indexed citations

20.

Thomas, Andrew W., et al.. (1994). Acute Pancreatitis as a Complication of Colonoscopy. Journal of Clinical Gastroenterology. 19(2). 177–177. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact